Whether positive or negative, your mood may feel different on GLP-1 medications. Researchers share why that might be and how ...
Terns Pharmaceuticals’ decision to drop its liver disease ambitions may yet pay off, after the biotech posted phase 1 data ...
An experimental weight-loss pill helped people drop 13% of their body weight in a three-month period. The results from early ...
The manufacturer of Ozempic is testing amycretin, an experimental weight-loss pill that appears to help people quickly shed ...
In early-stage trials, oral weight-loss drugs from Eli Lilly and Novo Nordisk have shown that they can help patients achieve ...
Treatments like GLP-1s are effective, but they're also extremely expensive. With GLP-1s rising in demand, it can pose a ...
Recently, GLP-1 receptor agonist medications have been prescribed more commonly, in part due to their ability to produce ...
The world's biggest food company is targeting Ozempic users with small, protein-packed meals for under $5.
However, the research found that exercising helped preserve bone loss. Experts said that the findings may apply to other ...
Phase I data for TERN-601 suggests Terns’ oral GLP-1 candidate for obesity could be a contender in the market next to big ...